Senestech (NASDAQ:SNES) Major Shareholder Acquires $29,087.10 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 15,390 shares of the business’s stock in a transaction on Friday, February 13th. The shares were acquired at an average cost of $1.89 per share, for a total transaction of $29,087.10. Following the transaction, the insider directly owned 633,700 shares in the company, valued at approximately $1,197,693. This trade represents a 2.49% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, February 12th, Glenbrook Capital Management acquired 7,956 shares of Senestech stock. The shares were acquired at an average price of $1.72 per share, for a total transaction of $13,684.32.
• On Wednesday, February 11th, Glenbrook Capital Management acquired 8,000 shares of Senestech stock. The shares were acquired at an average cost of $1.73 per share, for a total transaction of $13,840.00.
• On Thursday, February 5th, Glenbrook Capital Management bought 2,884 shares of Senestech stock. The shares were bought at an average cost of $1.77 per share, for a total transaction of $5,104.68.
• On Wednesday, February 4th, Glenbrook Capital Management purchased 5,685 shares of Senestech stock. The stock was bought at an average cost of $1.82 per share, with a total value of $10,346.70.
• On Monday, February 2nd, Glenbrook Capital Management acquired 42,739 shares of Senestech stock. The shares were bought at an average price of $1.98 per share, with a total value of $84,623.22.
• On Friday, January 30th, Glenbrook Capital Management bought 5,399 shares of Senestech stock. The stock was bought at an average price of $1.87 per share, for a total transaction of $10,096.13.

Senestech Stock Performance

Shares of Senestech stock opened at $2.00 on Monday. The company has a market capitalization of $10.44 million, a PE ratio of -0.55 and a beta of 0.22. The company has a 50-day simple moving average of $2.17 and a two-hundred day simple moving average of $3.40. Senestech, Inc. has a one year low of $1.30 and a one year high of $6.24. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC purchased a new stake in shares of Senestech during the 2nd quarter worth about $59,000. Jane Street Group LLC acquired a new stake in shares of Senestech in the fourth quarter valued at about $32,000. Diversify Advisory Services LLC acquired a new position in Senestech during the fourth quarter worth about $34,000. Essex Investment Management Co. LLC acquired a new stake in Senestech in the 3rd quarter valued at about $115,000. Finally, Millennium Management LLC acquired a new position in Senestech during the third quarter worth $126,000. 5.19% of the stock is currently owned by institutional investors and hedge funds.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.